Detecting and predicting pre-eclampsia

Details Detecting and predicting pre-eclampsia Detecting and predicting pre-eclampsia

2007-01-16

2009-12-29

Borin, Michael (Department: 1631)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C702S019000, C435S004000

Reexamination Certificate

active

07638287

ABSTRACT:
The technology described herein relates to methods of detecting or predicting pre-eclampsia (PE). The technology described herein also relates to commercial packages, such as diagnostic kits, for performing a method of detecting or predicting PE. In particular, the technology described herein provides methods of predicting pre-eclampsia when determining the levels of biochemical markers.

REFERENCES:
patent: WO 98/28006 (1998-07-01), None
patent: WO 02/37120 (2002-05-01), None
patent: WO 02/37120 (2002-05-01), None
Williams et al Am J Epidemiol 1999;149:323-329.
Bower et al. Obstetrics and Gynecology, 1993,82,78-83.
Merviel et al. European Journal of Obstetrics & Gynecology and Reproductive Biology , vol. 115, Issue 2, 2004, pp. 134-147.
Reith A et al: “Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole.” British Journal of Obstetrics and Gynaecology, vol. 100, No. 4, 1993, pp. 370-374, XP008005703, ISSN: 0306-5456.
Estelles A et al: “Changes In The Plasma Levels Of Type 1 And Type 2 Plasminogen Activator Inhibitors In Normal Pregnancy And In Patients With Severe Preeclampsia” Blood, vol. 74, No. 4, 1989, pp. 1332-1338, XP008005702. ISSN: 0006-4971.
Torry D S et al: “Preeclampsia is associated with reduced serum levels of placenta growth factor.” American Journal of Obstetrics and Gynecology. Dec. 1998, vol. 179, No. 6 Pt 1, pp. 1539-1544, XP008005712, ISSN: 0002-9378.
Anim-Nyame N et al: “Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and pre-eclampsia.” Human Reproduction Sep. 2000, vol. 15, No. 9, pp. 2033-2036, XP008005712, ISSN: 0268-1161.
Teppa R J et al: “Free leptin is increased in normal pregnancy and further increased in preeclampsia.”Metabolism: Clinical and Experimental. Aug. 2000, vol. 49, No. 8, pp. 1043-1048, XP008005711, ISSN: 0026-0495.
Coleman et al., Drug Discovery Today.2003. 8:233-235.
M. Kolben et al., “Measuring the Concentration of Various Plasma and Placenta Extract Proteolytic and Vascular Factors in Pregnant Patients with HELLP Syndrome, Pre-/Eclampsia and Highly Pathologic Doppler Flow Values,” Gynakologisch-Geburtshilflische Rundschau, 1995, vol. 35, Suppl 1, pp. 126-131.
I. S. Serin et al., “Predictive Value of Tumor Necrosis Factor Alpha (TNF-Alpha) in Preeclampsia,” European Journal of Obstetrics, Gynecology, and Reproductive Biology, Jan. 10, 2002, vol. 100, No. 2, pp. 143-145.
A.. H. Shennan et al., “Pre-Eclampsia” Contemporary Clinical Gynecology and Obstetrics, 2001, vol. 1, No. 4, pp. 353-364.
L. C. Chappell, et al., “A Longitudinal Study of Biochemical Variables in Women at Risk of Preeclampsia,” American Journal of Obstetrics & Gynecology, Jul. 2002, vol. 187, No. 1, pp. 127-136.
International Search Report and Written Opinion.

Affiliated with

Also associated with

Rating

Detecting and predicting pre-eclampsia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Detecting and predicting pre-eclampsia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detecting and predicting pre-eclampsia will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4098638